Mineralys Therapeutics, Inc.MLYSNASDAQ
Loading
Debt to Equity Over TimeElevated
Percentile Rank20
Studio
Year-over-Year Change

Debt-to-equity ratio

Latest
0.00
↑ 100% vs avg
Percentile
P20
Within normal range
Average
-0.21
Historical baseline
PeriodValueYoY Change
20250.00-
20240.00-
20230.00-
20220.00-
20210.00+100.0%
2020-1.25-